Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams, Scott Parker, Marnie Elizaga, +25

The Journal of Infectious Diseases

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Paul A. Goepfert, Marnie Elizaga, Alicia Sato, +17

The Journal of Infectious Diseases

Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults

Spyros A. Kalams, Scott Parker, Xia Jin, +13

PLoS ONE

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

Paul A. Goepfert, Marnie Elizaga, Kelly E. Seaton, +19

The Journal of Infectious Diseases

A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers

Paul Spearman, Michelle Lally, Marnie Elizaga, +12

The Journal of Infectious Diseases

Patients in Long-Term Care Facilities: A Reservoir for Vancomycin-Resistant Enterococci

Marnie Elizaga, Robert A. Weinstein, Mary K. Hayden

Clinical Infectious Diseases

Rectal ColonizationAntibioticsAntimicrobial StewardshipHealthcare-associated InfectionClinical Epidemiology +12

Safety profile of recombinant canarypox HIV vaccines

Guy de Bruyn, Anthony Rossini, Ya-Lin Chiu, +7

Vaccine

VaccinationVaccine DevelopmentImmunologyVirologyHiv +4

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Jonathan D. Fuchs, Ian Frank, Marnie Elizaga, +32

Open Forum Infectious Diseases

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

Marnie Elizaga, Shuying S. Li, Nidhi Kochar, +16

PLoS ONE

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

Paul Spearman, Spyros A. Kalams, Marnie Elizaga, +16

Vaccine

VaccinationVaccine DevelopmentVaccine TargetImmunologyVaccine Design +4